Approval · Notice of Compliance 9950 · 2008
NASONEX: Notice of Compliance 9950
Issued December 18, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9950
- Date
- December 18, 2008
- Company
- Schering-Plough Canada Inc.Pointe-Claire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication: use in adults and children 12 years of age and older in the treatment of symptoms associated with mild to moderate uncomplicated acute rhinosinusitis where signs or symptoms of bacterial infection are not present.
- Therapeutic class
- Corticosteroid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NASONEX | Not yet assigned | — |
Medicinal ingredients
- MOMETASONE FUROATE 50 MCG per SPR